• 24
    Apr

    AIFA Opens the Door: Patients Now Have a Seat at the HTA Table

    Italy's medicines agency AIFA has taken a significant step forward in how health technology assessment bodies [...]

    0 Comments

  • 14
    Apr

    The first JCA dossiers could arrive mid-2026; how will they impact market access?

    The Joint Clinical Assessment (JCA) framework represents a significant shift in how pharmaceutical products are evaluated [...]

    0 Comments

  • 8
    Jan
    Radicava oral suspension

    Shionogi’s Acquisition of Mitsubishi Tanabe Pharma’s Radicava Business

    Yesterday afternoon, I listened with interest to a presentation on Pharma’s Deal Review: M&A Dynamics Ahead [...]

    0 Comments

  • 1
    Dec
    A screenshot of the article about NICE's cost-effectiveness thresholds, on the NICE website

    Changes to NICE’s cost-effectiveness thresholds confirmed

    This change aims to enhance the operating environment for pharmaceutical companies in the UK, supporting innovation [...]

    0 Comments

  • 1
    Dec
    English and American flags

    Landmark UK-US trade deal

    On Wednesday, October 1, 2025, the UK-US landmark deal was announced on the government website. Tens [...]

    0 Comments

  • 1
    Dec
    A picture of dice depicting 2:1 to illustrate the article

    Navigating the challenges of Clinical Trials in Rare Disease

    Designing clinical trials for rare diseases requires balancing scientific rigour with practical realities. A key challenge [...]

    0 Comments

  • 18
    Nov
    A screenshot about VPAg from the APBI website, to illustrate the article

    Companies granted third extension to VPAG 2026

    The ABPI and the government have extended the deadline for companies to announce their exit from [...]

    0 Comments

  • 10
    Nov
    A screenshot of a White House fact sheet to illustrate the article

    Who will truly benefit? MFN deals

    AstraZeneca’s Agreement with the U.S. Government AstraZeneca announced a landmark agreement with the Trump administration to [...]

    0 Comments

  • 17
    Oct
    Graphic to illustrate article about synergistic combination therapy

    True synergistic combination therapy

    Over the last few weeks, I’ve noticed several online discussions about Combination Therapies. Having supported a [...]

    0 Comments

  • 16
    Oct
    Graphic of microscope to illustrate blog article about The Innovative Licensing and Access Pathway

    The UK’s ILAP Is accelerating medical innovation and it’s happening now!

    The Innovative Licensing and Access Pathway (ILAP), launched by the MHRA in 2021 and re-launched in [...]

    0 Comments